As of November 10, 2026, WORK Medical Technology Group LTD has Schedule 13D or 13G filings on record, none whose latest reports a stake of 5% or more. 9 filings are on record since September 29, 2025 (Schedule 13G/A, June 16, 2026).
Sell to companies like WORK Medical Technology Group LTD? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Habbas Kelly Khalid · Sole voting: 0 · Shared voting: 0 · Sole dispositive: 0 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-06-16
- · Holder: Habbas Kelly Khalid · Percent: 21.5% · SCHEDULE 13G/A
- · Holder: Trillium Trading, LLC · SCHEDULE 13G/A
- · Holder: Trillium Trading, LLC · Percent: 18% · SCHEDULE 13G
- · Holder: Habbas Kelly Khalid · Percent: 18.9% · SCHEDULE 13G
WORK Medical Technology Group LTD has 9 Schedule 13D or 13G filings on record since 2025-09-29. No holder's latest filing reports 5% or more. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Bigger Capital Fund L P | 0% | 0 | SCHEDULE 13G/A, 2025-10-14 | 2025-10-10 |
| L1 Capital Global Opportunities Master Fund, Ltd. | 0% | 0 | SCHEDULE 13G/A, 2025-11-14 | 2025-11-14 |
| 0% | 0 | SCHEDULE 13G/A, 2026-06-16 | 2026-06-15 | |
| Trillium Trading, LLC | SCHEDULE 13G/A, 2026-06-09 | 2026-06-05 |
Holding shares or following this stake? See who's behind WORK Medical Technology Group LTD and the warning signs.
Free to see. No signup.
Keep reading
More on WORK Medical Technology Group LTD and the records around it.
WORK Medical Technology Group LTD elsewhere on the record
- IPO filing May 2025
- Who owns it
Companies that share a holder
- BIGGER CAPITAL FUND L P also filed stake reports on 13 other companies: ClearPoint Neuro, Inc. (Nov 2026), Dermata Therapeutics, Inc. (Nov 2026), BTC Digital Ltd. (Oct 2026)
- L1 Capital Global Opportunities Master Fund, Ltd. also filed stake reports on 42 other companies: Youlife Group Inc. (Nov 2026), INLIF Ltd (Oct 2026), DarkIris Inc. (Oct 2026)
Watch WORK Medical Technology Group LTD
Get an email when WORK Medical Technology Group LTD files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on WORK Medical Technology Group LTD?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on WORK Medical Technology Group LTD: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on WORK Medical Technology Group LTD covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
17 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Habbas Kelly Khalid | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2026-06-16 |
The latest filing identifies WORK Medical Technology Group LTD by CUSIP G9767H125 and gives its principal executive office as 1/88 COOK ST, AUCKLAND CITY (SCHEDULE 13G/A, 2026-06-16).
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-09-29 | Bigger Capital Fund L P | 9.99% | SCHEDULE 13G |
| 2025-10-03 | L1 Capital Global Opportunities Master Fund, Ltd. | 9.99% | SCHEDULE 13G |
| 2025-10-14 | Bigger Capital Fund L P | 0% | SCHEDULE 13G/A |
| 2025-11-14 | L1 Capital Global Opportunities Master Fund, Ltd. | 0% | SCHEDULE 13G/A |
| 2026-06-04 | Habbas Kelly Khalid | 18.9% | SCHEDULE 13G |
| 2026-06-08 | Trillium Trading, LLC | 18% | SCHEDULE 13G |
| 2026-06-09 | Trillium Trading, LLC | SCHEDULE 13G/A | |
| 2026-06-10 | Habbas Kelly Khalid | 21.5% | SCHEDULE 13G/A |
| 2026-06-16 | Habbas Kelly Khalid | 0% | SCHEDULE 13G/A |
Also on the record for WORK Medical Technology Group LTD
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| May 22, 2025 | IPO filing, Form 424B4 | $0.5 a share | IPO filings | Source |
| April 29, 2025 | IPO filing, Form F-1/A | — | IPO filings | Source |
| April 9, 2025 | IPO filing, Form F-1/A | — | IPO filings | Source |
| December 23, 2024 | IPO filing, Form F-1 | — | IPO filings | Source |
| August 26, 2024 | IPO filing, Form 424B4 | — | IPO filings | Source |
| August 2, 2024 | IPO filing, Form F-1/A | — | IPO filings | Source |
| July 17, 2024 | IPO filing, Form F-1/A | — | IPO filings | Source |
| July 5, 2024 | IPO filing, Form F-1/A | — | IPO filings | Source |
Tools for this story
Each opens in a new tab, filled in for WORK Medical Technology Group LTD. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.